Analytic Investors’s BioTelemetry, Inc. BEAT Stock Holding History

Analytic Investors’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-118,188	Closed	-$1.38M	–	725
2015 Q4	$1.38M	Buy	118,188 +50,446	+74%	+$638K	0.02%	349
2015 Q3	$829K	Buy	67,742 +31,914	+89%	+$407K	0.01%	394
2015 Q2	$338K	Hold	35,828	–	–	﹤0.01%	502
2015 Q1	$317K	Buy	+35,828	New	+$362K	﹤0.01%	485

Other funds holding BEAT

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Analytic Investors's BEAT Position: Q1 2016 in Review

Analytic Investors sold out of BioTelemetry, Inc. (BEAT) in Q1 2016, closing a stake of 118,188 shares — an estimated $1.38M sold.

Analytic Investors first reported a position in BEAT in Q1 2015 and held it in 4 quarters. The position peaked at $1.38M in Q4 2015. 112 funds tracked by Wall St. Rank hold BEAT as of Q1 2016.

Analytic Investors reported no remaining BioTelemetry, Inc. position as of Q1 2016 after selling out during the quarter.
Analytic Investors sold 118,188 BioTelemetry, Inc. shares in Q1 2016, an estimated $1.38M.
Analytic Investors first reported a position in BioTelemetry, Inc. in Q1 2015 and held it in 4 quarters.
Analytic Investors's BioTelemetry, Inc. position peaked at $1.38M in Q4 2015.
112 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2016.

Based on Analytic Investors's 13F filing for Q1 2016, filed 20 May 2016.